
Our Mission
The Children’s Leukemia Research Association, established in 1965, is driven by a clear and vital mission: to advance the cause against blood cancer through research, with a focus on identifying its origins and developing curative solutions for leukemia and related blood disorders. Additionally, we extend our unwavering support to families grappling with the financial challenges of blood cancer-related expenses, both for children and adults.
The burden of cancer often brings unforeseen financial strain. Families suddenly find themselves grappling with mounting medical bills, reduced incomes due to caregiving responsibilities, and the necessity for one spouse to cease working during treatment. For many, cancer becomes synonymous with overwhelming financial stress.

At the Children’s Leukemia Research Association, we stand as a steadfast resource for families facing these trying circumstances and an integral catalyst for the progression of blood cancer research. Our operations are sustained by the generosity of compassionate donors who share our commitment to aiding blood cancer patients and advancing research towards the eradication of leukemia, lymphoma, and other blood-related disorders. Your support is not only essential but deeply appreciated in the pursuit of our mission.
We are proud to be part of this revolutionary scientific research.
We know there are cures on the horizon.
With your support, we are getting closer every day.
We’re able to help more patients with their medical bills.
We’re able to support the research that is changing lives.
And we cannot do this without you.

Who We Help
Since the early 2000s, the Children’s Leukemia Research Association has been a beacon of hope for individuals battling blood cancer. We extend vital support by covering medical expenses, including prescription copays and treatment-related costs, recognizing that cancer-related medical bills can place an immense financial burden on patients and their families.
WITHIN THE FIRST THREE YEARS FOLLOWING A DIAGNOSIS, A BLOOD CANCER PATIENT CAN EXPECT TO PAY ANYWHERE BETWEEN $200,000 to $800,000 ON TREATMENT ALONE.
In the challenging landscape of blood cancer treatment, our mission is clear: no one should have to worry about how their medical bills will be paid. Your invaluable support empowers us to help patients and propel advancements in treatments and cures.
- Since 2001, the CLRA Patient Aid Program has provided $1.4 million in co-pay reimbursements assistance to 600 patients with blood cancer and related diseases.
- 85 patients in 25 states were supported in the 2020/2021 fiscal year.
- 102 patients in 26 states were supported in 2020 at the height of the pandemic.
- 120 patients in 26 states were supported in 2022 with a record total of reimbursement over $240,000.
Remarkable progress is being made in the field of blood cancer research, with extended lives and saved lives standing as testament to these efforts. While not every patient enters remission, we remain resolute in our mission. Researchers, backed by the Children’s Leukemia Research Association, are at the forefront of studying tumors and harnessing the power of human genome sequencing to unveil the root causes of blood cancer. This promising avenue offers great hope, as a deeper understanding of the human genetic code is poised to usher in more effective treatments and, ultimately, life-saving cures.
Learn more on Research Grant Program.
Patients
Steps to Apply
Made possible through the generosity of our Donors, The CLRA Patient Aid Program has provided $1.4 million in co-pay reimbursements assistance, consisting of medical bills for treatments and medications including chemotherapy, IVIG, antibiotics, vitamins, and more.
Researchers
How the Program Works
For over 55 years, the Children’s Leukemia Research Association has remained at the forefront of blood cancer research. To this day, we’ve provided over $5,000,000 in grant funding to support over 550 researchers in groundbreaking blood cancer studies that are not replicated elsewhere.
Our Stories Illustrate the Impact
About Us
When you contact CLRA, you engage with our knowledgeable staff and dedicated volunteers who can readily connect you to essential resources. Our deep understanding of cancer’s financial toll comes from direct conversations with patients. The rapid accumulation of medical bills upon diagnosis and treatment is a stark reality. Insurance coverage may fall short, with denials or limited reimbursements
for critical procedures.
IIn contrast to larger cancer support organizations that employ income-based eligibility criteria, Children’s Leukemia Research Association prioritizes aiding families who, despite managing daily expenses, find themselves financially strained by the substantial added costs of cancer treatment. These are the individuals and families we are uniquely equipped to assist.


We are proud to receive Guidestar’s Platinum Transparency designation.